Feliza Mirasol

The complexity of newer biotherapeutic molecules calls for alternative drug delivery strategies.

Large-scale single-use bioreactors prove successful as limits are tested.

SUB bioreactor performance has had seen its limits and successes.

Establishing a data management strategy in-lab is a first step in generating successful analytical studies.